In Brief: Product development protocol workshop
This article was originally published in The Gray Sheet
Executive Summary
Product development protocol workshop: FDA and the Health Industry Manufacturers Association to hold public workshop Oct. 22 to gather input on the use of the PDP process as an alternate means of premarket approval for Class III devices. FDA's PDP guidelines will be discussed at the gathering, which will take place at the Renaissance Hotel in Washington, D.C. For further information, contact CDRH's Lillian Yin at 301/594-5072...